How scientific breakthroughs reshape industries, economies, and power.
AI as an economic actor, the GLP-1 revolution, longevity, synthetic biology,
and the forces redrawing who wins and who loses.
Weekly deep dives into AI drug discovery, computational biology, and pharma
R&D transformation. Published by BiopharmaTrend — the industry intelligence
platform I co-founded.
A Stanford study deployed thousands of AI agents to run autonomous research. What it reveals about the future of scientific work — and who captures the value.
The forgotten history of how synthetic chemistry created and destroyed national economies — and what it tells us about AI.
Jan 2026
About
I'm a biotech and AI analyst with a PhD in Physical Chemistry and over a decade
tracking the intersection of technology and life sciences. I co-founded
BiopharmaTrend.com, one of the earliest platforms covering AI in drug
discovery, and have published analytical work cited by institutional and academic
audiences worldwide. I write about the forces reshaping how science, technology,
and capital interact — from the lab to the boardroom to the geopolitical stage.